Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses

被引:36
作者
Ching, Kuan-Chieh [1 ,2 ]
Kam, Yiu-Wing [3 ]
Merits, Andres [4 ]
Ng, Lisa F. P. [3 ,5 ]
Chai, Christina L. L. [1 ,2 ,6 ]
机构
[1] Ctr Life Sci, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore
[2] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore 117543, Singapore
[3] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore
[4] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia
[5] Natl Univ Singapore, Ctr Translat Med, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore
[6] ASTAR, Inst Chem & Engn Sci, Singapore 138665, Singapore
关键词
CHIKUNGUNYA VIRUS-REPLICATION; NS5B POLYMERASE; ONYONG-NYONG; IDENTIFICATION; INFECTION; DISEASE; EPIDEMIOLOGY; ENCEPHALITIS; OPTIMIZATION; PATHOGENESIS;
D O I
10.1021/acs.jmedchem.5b01047
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chikungunya virus (CHIKV) is a re-emerging vector-borne alphavirus and is transmitted to humans by Aedes mosquitoes. Despite the re-emergence of CHIKV as an epidemic threat, there is no approved effective antiviral treatment currently available for CHIKV. Herein, we report the synthesis and structure activity relationship studies of a class of thieno [3,2-b]pyrroles and the discovery of a trisubstituted thieno[3,2-b]pyrrole 5-carboxamide 15c that exhibits potent inhibitory activity against in vitro CHIKV infection. Compound 15c displayed low micromolar activity (EC50 value of ca. 2 mu M) and limited cytotoxic liability (CC50 > 100 mu M) therefore furnishing a selectivity index of greater than 32. Notably, 15c not only controlled viral RNA production, but efficiently inhibited the expression of CHIKV nsP1, nsP3, capsid, and E2 proteins at a concentration as low as 2.5 mu M. More importantly, 15c also demonstrated broad spectrum antiviral activity against other clinically important alphaviruses such as O'nyong-nyong virus and Sindbis virus.
引用
收藏
页码:9196 / 9213
页数:18
相关论文
共 23 条
  • [21] Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors
    Wang, Yazhou
    Huang, Wei
    Xin, Minhang
    Chen, Pan
    Gui, Li
    Zhao, Xinxin
    Zhu, Xinrong
    Luo, Hongpeng
    Cong, Xin
    Wang, Jia
    Liu, Fei
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (12) : 2592 - 2597
  • [22] Design, synthesis and. biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3′,2′:3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5′-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes
    Zhou, Shengbin
    Duan, Yanan
    Wang, Jiang
    Zhang, Jin
    Sun, Haifeng
    Jiang, Haowen
    Gu, Zhanni
    Tong, Junhua
    Li, Jingya
    Li, Jia
    Liu, Hong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 140 : 448 - 464
  • [23] Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I
    Meng, Ge
    Zheng, Meilin
    Wang, Mei
    Tong, Jing
    Ge, Weijuan
    Zhang, Jiehe
    Zheng, Aqun
    Li, Jingya
    Gao, Lixin
    Li, Jia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 : 756 - 769